| scholarly article | Q13442814 |
| P50 | author | Valentín Fuster Carulla | Q977751 |
| Stephen D Dickson | Q57077628 | ||
| James H Rudd | Q57077698 | ||
| Willem J.M. Mulder | Q62656505 | ||
| Klaas Nicolay | Q38360372 | ||
| Edward A Fisher | Q38549204 | ||
| Raymond M. Schiffelers | Q39472386 | ||
| Venkatesh Mani | Q47840811 | ||
| John T. Fallon | Q51297855 | ||
| P2093 | author name string | Zahi A Fayad | |
| Gert Storm | |||
| Claudia Calcagno | |||
| Esad Vucic | |||
| Hai-Shan Wu | |||
| Josbert M Metselaar | |||
| Louis van Bloois | |||
| Manuela Banciu | |||
| Mark E Lobatto | |||
| Stephane Silvera | |||
| P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| Recent advances with liposomes as pharmaceutical carriers | Q29616702 | ||
| Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation | Q33244720 | ||
| Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. | Q33268808 | ||
| Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma | Q33597840 | ||
| Oncological applications of FDG PET imaging | Q33751562 | ||
| Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. | Q34132798 | ||
| Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies | Q34316368 | ||
| Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids | Q34381920 | ||
| Neovascularization in human atherosclerosis | Q34523545 | ||
| Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions | Q34918635 | ||
| Molecular, cellular and functional imaging of atherothrombosis | Q35936423 | ||
| Atherothrombosis and high-risk plaque: part I: evolving concepts | Q36259704 | ||
| Liposomes in the treatment of inflammatory disorders | Q36316769 | ||
| Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. | Q52578262 | ||
| Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. | Q53514180 | ||
| Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. | Q54301756 | ||
| The Year in Atherothrombosis | Q56986702 | ||
| Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 | ||
| In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients | Q79328884 | ||
| Therapeutic application of long-circulating liposomal glucocorticoids in auto-immune diseases and cancer | Q94491076 | ||
| Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue | Q36462801 | ||
| Exploiting the enhanced permeability and retention effect for tumor targeting | Q36578875 | ||
| Imaging of atherosclerotic cardiovascular disease | Q37089743 | ||
| Form to function: current and future roles for atherosclerosis imaging in drug development | Q37165155 | ||
| Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. | Q38713992 | ||
| Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice | Q39964878 | ||
| Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations | Q40091380 | ||
| Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice | Q40278836 | ||
| Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis | Q40581554 | ||
| Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression | Q40868885 | ||
| Functional inhibition of NF-kappaB signal transduction in alphavbeta3 integrin expressing endothelial cells by using RGD-PEG-modified adenovirus with a mutant IkappaB gene | Q42136598 | ||
| Liposomal Alendronate Inhibits Systemic Innate Immunity and Reduces In-Stent Neointimal Hyperplasia in Rabbits | Q42452499 | ||
| Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits | Q43545495 | ||
| Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes | Q44504463 | ||
| Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles | Q44616397 | ||
| (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study | Q44964637 | ||
| Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography | Q46535642 | ||
| Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice | Q46624409 | ||
| MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. | Q46735498 | ||
| Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice | Q46740495 | ||
| (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. | Q48904408 | ||
| A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. | Q51643528 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 2020-2029 | |
| P577 | publication date | 2010-11-08 | |
| P1433 | published in | Molecular Pharmaceutics | Q3011140 |
| P1476 | title | Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis | |
| P478 | volume | 7 |
| Q38067933 | Advances in nanotechnology for the management of coronary artery disease |
| Q48235332 | Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in mice. |
| Q26860162 | Anti-inflammatory therapy in chronic disease: challenges and opportunities |
| Q89823704 | Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q30364399 | Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications. |
| Q41854592 | Atherosclerotic plaque inflammation quantification using dynamic contrast-enhanced (DCE) MRI. |
| Q27334823 | Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging |
| Q45209173 | Buccal films of prednisolone with enhanced bioavailability |
| Q48324738 | Combined treatment with recombinant tissue plasminogen activator and dexamethasone phosphate-containing liposomes improves neurological outcome and restricts lesion progression after embolic stroke in rats. |
| Q38848673 | Detection and treatment of atherosclerosis using nanoparticles |
| Q26749689 | Dynamic Contrast-Enhanced MRI to Study Atherosclerotic Plaque Microvasculature |
| Q57340480 | Functional Nanomaterials for Multifarious Nanomedicine |
| Q38094125 | Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis. |
| Q35795262 | HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages |
| Q36412437 | Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits |
| Q53556906 | Homologous HOmologous Black-Bright-blood and flexible Interleaved imaging sequence (HOBBI) for dynamic contrast-enhanced MRI of the vessel wall. |
| Q27002916 | Imaging and nanomedicine in inflammatory atherosclerosis |
| Q36728733 | Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging |
| Q27322891 | Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model. |
| Q30464757 | Liposomes in diagnosis and treatment of cardiovascular disorders. |
| Q39003364 | Local Inhibition of Macrophage and Smooth Muscle Cell Proliferation to Suppress Plaque Progression. |
| Q36870901 | Making things stick in the fight against atherosclerosis |
| Q38090583 | Molecular MRI of the Cardiovascular System in the Post-NSF Era |
| Q58592672 | Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3) |
| Q33949943 | Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease. |
| Q46546902 | Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques. |
| Q35681183 | Nanomedical Theranostics in Cardiovascular Disease. |
| Q39136197 | Nanomedicine applied to cardiovascular diseases: latest developments. |
| Q39276023 | Nanomedicine in coronary artery disease |
| Q36651592 | Nanomedicines for Endothelial Disorders |
| Q37627094 | Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes |
| Q91754431 | Nanoparticle Therapy for Vascular Diseases |
| Q91579180 | Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy |
| Q26798426 | Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and Features |
| Q34736942 | Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery. |
| Q30455490 | Perspectives and opportunities for nanomedicine in the management of atherosclerosis. |
| Q35831733 | Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy. |
| Q38469591 | Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging |
| Q36223678 | Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration |
| Q30357131 | Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound. |
| Q47147736 | Protein Mimetic and Anticancer Properties of Monocyte-Targeting Peptide Amphiphile Micelles. |
| Q47251361 | Recent Advances in Managing Atherosclerosis via Nanomedicine. |
| Q47642528 | Recent Advances in Treatment of Coronary Artery Disease: Role of Science and Technology. |
| Q38459399 | Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin |
| Q50187351 | Resident and Monocyte-Derived Macrophages in Cardiovascular Disease |
| Q41238952 | SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries |
| Q38092246 | Small animal positron emission tomography imaging and in vivo studies of atherosclerosis |
| Q59017725 | The Mutual Beneficial Effect between Medical Imaging and Nanomedicine |
| Q37296851 | The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. |
| Q38193333 | Theranostic nanoparticles for cancer and cardiovascular applications |
| Q41839877 | Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques |
| Q88083584 | Ultrasound Molecular Imaging of Atherosclerosis Using Small-Peptide Targeting Ligands Against Endothelial Markers of Inflammation and Oxidative Stress |
| Q57340460 | Utility and Potential Application of Nanomaterials in Medicine |
| Q37868709 | Vascular imaging with positron emission tomography. |
| Q47794497 | Vessel wall characterization using quantitative MRI: what's in a number? |
| Q38187881 | Visualizing the atherosclerotic plaque: a chemical perspective |
Search more.